380 related articles for article (PubMed ID: 35682775)
1. Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer's Disease?
Hindle A; Singh SP; Pradeepkiran JA; Bose C; Vijayan M; Kshirsagar S; Sawant NA; Reddy PH
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682775
[TBL] [Abstract][Full Text] [Related]
2. RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer's Disease.
Awasthi S; Hindle A; Sawant NA; George M; Vijayan M; Kshirsagar S; Morton H; Bunquin LE; Palade PT; Lawrence JJ; Khan H; Bose C; Reddy PH; Singh SP
Cells; 2021 Nov; 10(11):. PubMed ID: 34831336
[TBL] [Abstract][Full Text] [Related]
3. The role of RLIP76 in oxidative stress and mitochondrial dysfunction: Evidence based on autopsy brains from Alzheimer's disease patients.
Bose C; Kshirsagar S; Vijayan M; Kumar S; Singh SP; Hindle A; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166932. PubMed ID: 37926360
[TBL] [Abstract][Full Text] [Related]
4. Rlip overexpression reduces oxidative stress and mitochondrial dysfunction in Alzheimer's disease: Mechanistic insights.
Reddy PH; Kshirsagar S; Bose C; Pradeepkiran JA; Hindle A; Singh SP; Reddy AP
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166759. PubMed ID: 37225106
[TBL] [Abstract][Full Text] [Related]
5. Abnormal interaction of Rlip with mutant APP/Abeta and phosphorylated tau reduces wild-type Rlip levels and disrupt Rlip function in Alzheimer's disease.
Baig J; Sawant N; Rawat P; Reddy AP; Reddy PH; Kshirsagar S
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166858. PubMed ID: 37633469
[TBL] [Abstract][Full Text] [Related]
6. Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights.
Reddy PH; Kshirsagar S; Bose C; Pradeepkiran JA; Hindle A; Singh SP; Reddy AP; Baig J
Cells; 2023 Jun; 12(12):. PubMed ID: 37371116
[TBL] [Abstract][Full Text] [Related]
7. Molecular Basis of Alzheimer's Disease: Focus on Mitochondria.
Oliver DMA; Reddy PH
J Alzheimers Dis; 2019; 72(s1):S95-S116. PubMed ID: 30932888
[TBL] [Abstract][Full Text] [Related]
8. Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.
Tönnies E; Trushina E
J Alzheimers Dis; 2017; 57(4):1105-1121. PubMed ID: 28059794
[TBL] [Abstract][Full Text] [Related]
9. Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
Bhatti JS; Kaur S; Mishra J; Dibbanti H; Singh A; Reddy AP; Bhatti GK; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166798. PubMed ID: 37392948
[TBL] [Abstract][Full Text] [Related]
10. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
11. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
12. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
Bhatia V; Sharma S
J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Dysfunction in Neocortex and Hippocampus of Olfactory Bulbectomized Mice, a Model of Alzheimer's Disease.
Avetisyan AV; Samokhin AN; Alexandrova IY; Zinovkin RA; Simonyan RA; Bobkova NV
Biochemistry (Mosc); 2016 Jun; 81(6):615-23. PubMed ID: 27301290
[TBL] [Abstract][Full Text] [Related]
14. Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer's Disease and Identifying Promising Drug Targets.
Fišar Z
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421690
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.
Calkins MJ; Reddy PH
Biochim Biophys Acta; 2011 Apr; 1812(4):507-13. PubMed ID: 21241801
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
Cai Q; Tammineni P
J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
19. Gain of PITRM1 peptidase in cortical neurons affords protection of mitochondrial and synaptic function in an advanced age mouse model of Alzheimer's disease.
Du F; Yu Q; Yan S; Zhang Z; Vangavaragu JR; Chen D; Yan SF; Yan SS
Aging Cell; 2021 May; 20(5):e13368. PubMed ID: 33951271
[TBL] [Abstract][Full Text] [Related]
20. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
